Cargando…

Rab22a is a novel prognostic marker for cell progression in breast cancer

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	He, Miao, Shen, Leihua, Jiang, Chengwei, Gao, Ge, Wang, Keren, Jiao, Yan, Sun, Liang, Cui, Yingnan, Ke, Zirui, Yang, Zhaoying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834961/ https://www.ncbi.nlm.nih.gov/pubmed/33655335 http://dx.doi.org/10.3892/ijmm.2021.4851

Ejemplares similares

Rab22a is a novel prognostic marker for cell progression in breast cancer
por: He, Miao, et al.
Publicado: (2020)

Wntless (Wls): A Prognostic Index for Progression and Patient Survival of Breast Cancer
por: Zheng, Dandan, et al.
Publicado: (2020)

Risk factors of breast intraductal lesions in patients without pathological nipple discharge
por: Shen, Leihua, et al.
Publicado: (2020)

Cysteine conjugate beta-lyase 2 (CCBL2) expression as a prognostic marker of survival in breast cancer patients
por: Meng, Xiangyu, et al.
Publicado: (2022)

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received
por: Dawson, S-J, et al.
Publicado: (2010)

Expression and prognostic significance of TRPV6 in the development and progression of pancreatic cancer
por: Song, He, et al.
Publicado: (2022)

Corrigendum to “PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer”
por: Li, Guang, et al.
Publicado: (2021)

Corrigendum to “Chaperone-Mediated Autophagy Markers LAMP2A and HSC70 Are Independent Adverse Prognostic Markers in Primary Resected Squamous Cell Carcinomas of the Lung”
por: Losmanová, Tereza, et al.
Publicado: (2021)

Corrigendum to “Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma”
por: Dai, Xiao-Meng, et al.
Publicado: (2017)

Corrigendum to Long Noncoding RNA PTTG3P Expression Is an Unfavorable Prognostic Marker for Patients With Hepatocellular Carcinoma
Publicado: (2020)

Translational Science 22 conference proceedings – CORRIGENDUM
por: Pliakos, Elina E., et al.
Publicado: (2023)

Characterization of prognostic value and immunological roles of RAB22A in hepatocellular carcinoma
por: Wen, Fukai, et al.
Publicado: (2023)

Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer
por: Sakaguchi, Takashi, et al.
Publicado: (2018)

Corrigendum to “Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively”
por: Yu, Qi, et al.
Publicado: (2018)

GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer
por: Ouyang, Fei, et al.
Publicado: (2021)

The lncRNA HOXA11-AS Regulates Rab3D Expression by Sponging miR-125a-5p Promoting Metastasis of Osteosarcoma [Corrigendum]
Publicado: (2021)

PLK1 as a potential prognostic marker of gastric cancer through MEK-ER K pathway on PDTX models [Corrigendum]
Publicado: (2019)

Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time
por: Melvin, Jennifer C, et al.
Publicado: (2016)

Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer
por: Al-Ejeh, F, et al.
Publicado: (2014)

Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment
por: Araujo, Angela M., et al.
Publicado: (2022)

Stent retriever thrombectomy combined with local thrombolytic therapy for cerebral venous sinus thrombosis: A case report
por: Chen, Chengwei, et al.
Publicado: (2018)

Correction to: Prognostic Features of Signal Transducer and Activator of Transcription 3 in an ER(+) Breast Cancer Model System
por: Liu, Li-Yu D, et al.
Publicado: (2014)

Development and Validation of a Prognostic Classifier Based on Lipid Metabolism-Related Genes for Breast Cancer [Corrigendum]
Publicado: (2022)

Corrigendum to “DNA methylation markers for oral pre-cancer progression: A critical review” [Oral Oncology 53 (2015) 1–9]
por: Shridhar, Krithiga, et al.
Publicado: (2016)

NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22
por: Spalinger, Marianne R., et al.
Publicado: (2023)

53 The development of a multi-institutional prospective registry for patients with metastatic invasive lobular carcinoma: identifying new markers of disease progression – CORRIGENDUM
por: Rothschild, Harriet T, et al.
Publicado: (2023)

Lpg0393 of Legionella pneumophila Is a Guanine-Nucleotide Exchange Factor for Rab5, Rab21 and Rab22
por: Sohn, Young-Sik, et al.
Publicado: (2015)

Simvastatin inhibits the apoptosis of hippocampal cells in a mouse model of Alzheimer's disease
por: Hu, Xiaoqin, et al.
Publicado: (2018)

Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis
por: White, N M A, et al.
Publicado: (2017)

The secretory small GTPase Rab27B as a marker for breast cancer progression
por: Hendrix, An, et al.
Publicado: (2010)

Anti-phospholipase A2 receptor antibody as a prognostic marker in patients with primary membranous nephropathy [Volume 37, Issue 3, September 2018, Pages 248–256]
por: Song, Eun Joo, et al.
Publicado: (2018)

Corrigendum to “The Prognostic Significance of Tumor Deposit Count for Colorectal Cancer Patients after Radical Surgery”
por: Zheng, Kuo, et al.
Publicado: (2020)

Corrigendum to “Fibrinogen as a Prognostic Predictor in Pediatric Patients with Sepsis: A Database Study”
por: Tang, Xiaomeng, et al.
Publicado: (2021)

Knockdown of pseudogene DUXAP8 expression in glioma suppresses tumor cell proliferation
por: Zhao, Xu, et al.
Publicado: (2020)

TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma
por: Ye, Song, et al.
Publicado: (2022)

TIP60-miR-22 axis as a prognostic marker of breast cancer progression
por: Pandey, Amit Kumar, et al.
Publicado: (2015)

Corrigendum to “The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma”
por: Kang, Weiting, et al.
Publicado: (2020)

Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”
por: Wang, TingAn, et al.
Publicado: (2021)

miR-23b suppresses lung carcinoma cell proliferation through CCNG1
por: Han, Hongsheng, et al.
Publicado: (2019)

miR-23a suppresses pancreatic cancer cell progression by inhibiting PLK-1 expression
por: Chen, Bin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sng2cg3vlbu92tgvc79svb8h4c